Novii External Fetal Monitoring Device (Novii)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03156608 |
Recruitment Status :
Completed
First Posted : May 17, 2017
Last Update Posted : November 1, 2017
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pregnancy Related Fetal Distress | Device: Novii ECG/EKG System Device: External fetal heart rate monitoring | Not Applicable |
Interpretation of fetal heart rate monitoring during labor is one of the most common procedures performed in the practice of obstetrics. Continuous monitoring of the fetal heart rate is used to identify infants at risk for hypoxic ischemic encephalopathy and allow for intervention to prevent this terrible complication. The quality of the fetal heart rate signal is critical for appropriate interpretation of the characteristics that identify risk.
This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI.
Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced Maternal Fetal Medicine (MFM) physicians who will assess the tracing for quality and interpretability. In addition, both approaches will be compared with respect to the need for additional monitoring modalities, amount of nursing intervention, cost and satisfaction of the patients and healthcare providers.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 218 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Women will be randomized to either standard monitoring with external Doppler and tocodynamometer or monitoring with the Novii Fetal ECG/EMG system using a computer generated randomization scheme through REDCap. Randomization will occur in blocks based on the subject's BMI. Women with a BMI < 30 will be randomized separate from women with a BMI > 30. |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison |
Actual Study Start Date : | March 6, 2017 |
Actual Primary Completion Date : | June 28, 2017 |
Actual Study Completion Date : | June 28, 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: Novii Device ECG/EMG System
These patients will have the Novii ECG/EMG system placed throughout labor and delivery, unless a provider or investigator determines that a different device (internal or external) is necessary for a better signal.
|
Device: Novii ECG/EKG System
External fetal heart rate monitoring |
Active Comparator: Standard of Care External Monitor
A standard external monitor will be placed throughout labor and delivery, unless a provider or investigator determines that an internal device is necessary for a better signal.
|
Device: External fetal heart rate monitoring
External fetal heart rate monitoring |
- Amount of time in minutes with the interpretable fetal heart rate tracing during the course of labor. [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]
Quality of the fetal heart rate for each minute of tracing will be assessed visually by 2 or more blinded reviewers. For the purpose of this study, uninterpretable fetal heart rate will be defined as continuous fetal heart rate data with one or more of the following:
- Data is missing for more than 75% of the minute of tracing
- Artifact is present for more than 25% of the minute of tracing
-
Missing data or artifact prevents determination of baseline rate
- > 15 seconds of continuous missing tracing
- Missing data is not continuous but is sufficiently frequent that the one minute segment of tracing could not be used to determine baseline rate
The total number of interpretable minutes of fetal heart tracing and the percentage of time with interpretable fetal heart tracing over the course of labor (Number of minutes with interpretable FHR/Total number of minutes in labor) will be calculated for each patient.
- Quality and interpretability of the FHT in ten minute segments [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]a. Each 10 minute segment will be deemed to be interpretable if it meets all of the following criteria: i. Sufficient data are available to determine a baseline ii. Sufficient data are available to determine the variability of the tracing iii. Sufficient data are available to identify periodic changes in the tracing (e.g. accelerations, decelerations, etc) b. For each 10 minute segment that is called Uninterpretable, the reviewer will indicate the reason for this designation by selecting one of the following options: i. Poor signal quality due to missing data ii. Poor signal quality due to artifact iii. Adequate signal quality but intrinsic fetal heart rate makes interpretation impossible (e.g. marked variability, etc.)
- Number and quality of uterine contractions in each 10 minute segment: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]The number of uterine contractions per segment will be recorded b. Signal quality (amount of missing data or artifact) will be recorded
- Number and quality of uterine contractions in each 10 minute segment: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Signal quality (amount of missing data or artifact) will be recorded
- Number of times fetal heart rate monitor requires adjusting: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Measured by recording the number of times the nurse must adjust the monitoring system to obtain interpretable tracing
- Number of times fetal heart rate monitor requires adjusting: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Number of times that hand holding of the monitor is required
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Need for additional monitoring devices will be determined by the clinical care team including attending physician and/or nurses based on clinical judgment
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Reason 1: Poor signal quality - missing data Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Reason 4: Patient preference Reason 5: Provider preference
- Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Reason 5: Provider preference
- Nursing time required for care: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]We will record the amount of time that the nurses spend at the bedside to adjust the monitor b. Nurses will record the time and reasons that they enter the room
- Nursing time required for care: [ Time Frame: Time of randomization until time of delivery (up to 48 hours) ]Nurses will record the time and reasons that they enter the room
- Overall cost of care: [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Total charge for care from admission to Labor and Delivery to transfer to postpartum care will be recorded for all patients
- Overall cost of care: [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Delivery type and indication
- Maternal outcomes - Length of labor [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Length of labor recorded
- Maternal outcomes - Delivery type [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Type of delivery recorded (e.g., vaginal, cesarean section, etc.)
- Maternal outcomes - Indication for forceps/vacuum extraction or cesarean section, if performed [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Clinical indication for forceps/vacuum extraction or cesarean section delivery
- Maternal outcomes - Estimated blood loss [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Amount of blood loss (cc) recorded
- Maternal outcomes - Presence and severity of perineal lacerations [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Lacerations and degree of laceration recorded
- Maternal outcomes - Intra-amniotic infection (clinical chorioamnionitis or triple I) [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Infections documented
- Maternal outcomes - Presence of clinical endometritis [ Time Frame: Hospitalization for labor, delivery, and recovery - 2-4 days ]Endometritis diagnosis recorded
- Neonatal outcomes - APGAR Scores [ Time Frame: Hospitalization after delivery - 2-4 days ]APGAR scores recorded at 1 minute, 5 minutes, and 10 minutes
- Neonatal outcomes - Need for ICU Admission [ Time Frame: Hospitalization after delivery - 2-4 days ]Recorded NICU admission
- Neonatal outcomes - Birthweight [ Time Frame: Hospitalization after delivery - 2-4 days ]Infant birthweight (grams)
- Neonatal outcomes - Neonatal Sex [ Time Frame: Hospitalization after delivery - 2-4 days ]Neonatal sex recorded
- Patient and provider satisfaction - Patient Survey [ Time Frame: Up to 7 days after delivery ]Satisfaction survey completed by patient after delivery of infant
- Patient and provider satisfaction - Nurse Survey [ Time Frame: Up to 7 days after delivery ]Satisfaction survey completed by nurse attending labor/delivery after delivery of infant
- Patient and provider satisfaction - Attending Physician/Midwife Survey [ Time Frame: Up to 7 days after delivery ]Satisfaction survey completed by physician/midwife attending labor/delivery after delivery of infant

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Pregnant women ≥ 18 years of age; gestational age ≥ 37 weeks
- Singleton pregnancy.
-
These women will be those presenting to Labor and Delivery for one of the following:
- Rule out labor
- Spontaneous labor
- Induction of labor
Exclusion Criteria:
- Age < 18 years old; multiple gestation pregnancy; gestational age < 37 weeks
- Fetal distress or vaginal bleeding prior to monitor placement
- Previous cesarean section
- Planned cesarean delivery.
- Women who are enrolled in the study but have less than 1 hour of fetal heart rate monitoring after randomization will be excluded from analysis.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03156608
United States, Utah | |
Intermountain Medical Center | |
Murray, Utah, United States, 84107 | |
McKay-Dee Hospital | |
Ogden, Utah, United States, 84403 | |
Utah Valley Hospital | |
Provo, Utah, United States, 84604 | |
LDS Hospital | |
Salt Lake City, Utah, United States, 84143 |
Principal Investigator: | Michael S Esplin, MD | Staff Physician |
Publications:
Responsible Party: | Michael Sean Esplin, Professor, Division of Maternal Fetal Medicine, Intermountain Health Care, Inc. |
ClinicalTrials.gov Identifier: | NCT03156608 History of Changes |
Other Study ID Numbers: |
1050411 |
First Posted: | May 17, 2017 Key Record Dates |
Last Update Posted: | November 1, 2017 |
Last Verified: | October 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Device Product Not Approved or Cleared by U.S. FDA: | Yes |
Pediatric Postmarket Surveillance of a Device Product: | No |
Product Manufactured in and Exported from the U.S.: | No |
External Fetal Heart Rate Monitor Fetal Heart Rate Monitor |
Fetal Distress Signs and Symptoms |